Eli Lilly's Retatrutide Offered for Compassionate Use: Eligibility Details | Retatrutide News

Eli Lilly is offering its experimental GLP-1 agonist, Retatrutide, for compassionate use to patients in need. This move allows access to the drug for th...
Market News · October 25, 2026